In this review
Ask how the resources become usable support
The reviewed GLP-1 pages describe ongoing support. Alan advertises fitness programs, dietitian-designed meal plans and lifestyle tips on a separate treatment page. Ask which of those resources come with your selected plan. The GLP-1 pages do not establish scheduled dietitian visits like those offered through Nourish or a guaranteed clinical reply time. I would ask who helps when meals become difficult, how progress is reviewed and whether a planned follow-up is a message, form or live visit. [1] [2] [8]
Support staff availability is listed as 9 am to 5 pm Eastern on weekdays. The homepage’s 40-plus-biomarker programme language also needs clarification: the actual at-home lab page is marked coming soon with a waitlist. Do not budget it as a currently included kit or complete prepaid test panel. Verify the selected service and any outside testing fees. [3] [5] [6]
Compare the amount at risk on the first order
The semaglutide page advertises a $158 monthly equivalent with a buy-one-month/get-one-free promotion and two months prepaid. Tirzepatide starts at $325 per month on a six-month prepaid plan. AquaVita lists total prices for three-month purchases, so ask for the equivalent upfront invoice from Alan before comparing the cash due. Later charges and promotional eligibility also need confirmation. [1] [2]
Although the product pages say the price stays the same at every dose, the general terms’ first-month promotion clause allows higher requirements to cost more. That makes a written selected-plan quote important. A smaller monthly equivalent is not a reason to choose a prescribed amount or commit beyond what the household budget can manage. [1] [2] [4]
Evaluate the medicine independently of the service’s convenience
The reviewed offers are compounded medicines, not approved-brand generics. The pages list possible added ingredients without defining every individual prescription or proving improved tolerability. Confirm the full formula, quantity, dispenser and label instructions. A testing badge or pharmacy category does not independently verify the assigned batch or establish the expected personal result. [1] [2] [7]
For GLP-1 shipping, FDA advises against using an injectable product that arrives warm or insufficiently refrigerated. This is stricter than the reassurance on Alan’s support page. Contact the dispensing pharmacy about a questionable delivery rather than treat general marketing language as safety clearance. [3] [7]
Stop the next charge before processing starts
Support says payment is upfront and physician nonapproval brings a full refund. Approved processing is different: cancellation is unavailable once medical review is submitted and the order is being processed. Prescription sales are final, and the terms do not promise refunds for partly used periods. Dispensing errors and delivery problems need review rather than an assumed automatic remedy. [3] [4]
The first renewal may process up to five business days early. Section 14 requires cancellation three business days before actual processing, while later wording uses three days before term start. Ask for the actual date and follow the stricter deadline. Pauses may resume billing automatically. I would choose this service only after the support, supply and stopping arrangement fit the intended routine. [4]
Understanding the cost
Compounded semaglutide’s $158 monthly equivalent is a two-month prepaid promotion; tirzepatide’s $325 equivalent requires six months prepaid. Confirm full invoice, later charges, supply and required testing. Three business days before actual renewal processing is the stricter published cancellation condition; a nominal term-end date may be too late.
Build your cost estimateSources
- Alan Health: compounded semaglutide promotion and preparation
- Alan Health: compounded tirzepatide and six-month prepayment
- Alan Health: current billing, nonapproval, processing and support answers
- Alan Health: complete April 7, 2025 subscription and payment terms
- Alan Health: at-home lab testing page marked coming soon
- Alan Health: programme scope and biomarker marketing
- FDA: concerns with unapproved GLP-1 drugs used for weight loss
- Alan Health: lifestyle resources described on the metformin page
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.